IGF-1 LR3
10MG
IGF-1 Receptor Signaling. Advanced Cellular Research.
IGF-1 LR3 (Long R3 IGF-1) is an 83-amino-acid analogue of insulin-like growth factor 1 engineered with an Arg substitution at position 3 and a 13-amino-acid N-terminal extension. These changes markedly reduce binding to IGF-binding proteins while retaining activity at the IGF-1 receptor, making it useful for laboratory studies of growth-factor signaling, cell proliferation, survival and metabolic pathways. Human therapeutic benefits have not been established.
A Healthier Tomorrow
IGF-1 LR3
10MG
$100.00 — or Original price was: $100.00.$90.00Current price is: $90.00. / month
Ships within 1-2 Business Days
Subscribe monthly and save 10%
- Ship to Canada,USA & Mexico
- Secure Checkout
- Add to wishlist
PREMIUM QUALITY:
Pharmaceutical-grade
INDEPENDENT TESTING:
Quality verification
BATCH TRANSPARENCY:
Product information
GLOBAL ACCESS:
Canada, USA & Mexico
SUPPORTING A HEALTHIER YOU
IGF Signaling. Cellular Research.
IGF-1 LR3 (Long R3 IGF-1) is primarily used in laboratory and preclinical models to study IGF-1 receptor signaling and growth-related cellular pathways. Research has explored its effects on cell proliferation, survival and metabolism in cell culture and animal models. Human clinical efficacy and safety have not been established.
- IGF-1 receptor activity
- Reduced IGFB-binding protein interaction
- Cell proliferation research
- Muscle-cell signaling models
- Metabolic pathways research
KEY AREAS OF HUMAN
KEY AREAS OF HUMAN
The Science
Evidence & Mechanism
Long R3 IGF-1 remains active at the IGF-1 receptor while showing greatly reduced affinity for IGF-binding proteins. In human fibroblast cell studies it produced stronger proliferative responses than native IGF-1, while most broader evidence comes from cell-culture and animal research. Human therapeutic safety and efficacy for IGF-1 LR3 have not been established.
Product Information
| Product Name | IGF-1 LR3 (Long R3 IGF-1) |
| Class | 83-amino-acid IGF-1 analogue |
| Composition | Native IGF-1 framework with Arg substitution at position 3 plus 13-amino-acid N-terminal extension |
| Strength | 10 mg |
| Vial Size | 3 mL |
| Purity | Confirm per current batch COA |
| Product Format | Lyophilized powder |
| Storage | 2–8°C, dry, protected from light |
| Intended Use | Laboratory research only. Not approved for human or veterinary use. |
Why Choose Nextgen
- Premium quality research products
- Independent laboratory testing
- Batch transparency
- Consistent quality standards
- Milligram App integration
- Dedicated customer support
FREQUENTLY ASKED QUESTIONS
Your Questions, Answered.
Find quick answers to common questions about this Product.
IGF-1 LR3 is a modified form of insulin-like growth factor 1 (IGF-1) designed with structural changes that affect its binding to IGF-binding proteins. It is primarily discussed in laboratory research investigating IGF-related signaling, cell growth, and metabolic processes. Research findings should not be interpreted as proof of safety or effectiveness in humans.
IGF-1 LR3 is studied in laboratory settings to investigate insulin-like growth factor signaling and its role in cellular growth, proliferation, and metabolism. Its research applications depend on the specific experimental model and study design. It is not approved as a treatment for human use.